News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
306,214 Results
Type
Article (15544)
Company Profile (283)
Press Release (290387)
Multimedia
Podcasts (54)
Webinars (7)
Section
Business (94060)
Career Advice (193)
Deals (15867)
Drug Delivery (48)
Drug Development (52289)
Employer Resources (39)
FDA (6461)
Job Trends (6706)
News (164258)
Policy (11155)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (1)
2024 BioMidwest Digital (4)
2024 Bio NC Digital (4)
2024 Biotech Bay Standard (10)
2024 Biotech Beach Digital (5)
2024 Biotech Beach Standard (3)
2024 Genetown Digital (7)
2024 Genetown Standard (6)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (4)
2024 Pharm Country Standard (3)
2025 BioForest Digital (3)
2025 Lone Star Bio Digital (3)
2026 BioMidwest Elite (1)
2026 Bio NC Standard (1)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Genetown Standard (1)
2026 Pharm Country Elite (1)
2026 Pharm Country Standard (1)
Academia (1000)
Accelerated approval (2)
Adcomms (13)
Allergies (58)
Alliances (23981)
ALS (65)
Alzheimer's disease (870)
Antibody-drug conjugate (ADC) (107)
Approvals (6488)
Artificial intelligence (145)
Autoimmune disease (18)
Automation (9)
Bankruptcy (114)
Best Places to Work (5395)
BIOSECURE Act (8)
Biosimilars (53)
Biotechnology (234)
Bladder cancer (61)
Brain cancer (21)
Breast cancer (168)
Cancer (1597)
Cardiovascular disease (135)
Career advice (167)
Career pathing (2)
CAR-T (134)
Cell therapy (365)
Cervical cancer (9)
Clinical research (42510)
Collaboration (588)
Compensation (266)
Complete response letters (17)
COVID-19 (1107)
CRISPR (42)
C-suite (184)
Cystic fibrosis (81)
Data (1604)
Denatured (11)
Depression (33)
Diabetes (154)
Diagnostics (2014)
Digital health (7)
Diversity (2)
Diversity, equity & inclusion (11)
Drug discovery (90)
Drug pricing (37)
Drug shortages (5)
Duchenne muscular dystrophy (90)
Earnings (36447)
Editorial (18)
Employer branding (4)
Employer resources (36)
Events (51250)
Executive appointments (528)
FDA (7235)
Featured Employer (30)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (560)
Gene editing (97)
Generative AI (13)
Gene therapy (270)
GLP-1 (416)
Government (1229)
Grass and pollen (3)
Guidances (30)
Healthcare (7958)
Huntington's disease (23)
IgA nephropathy (26)
Immunology and inflammation (106)
Indications (24)
Infectious disease (1185)
Inflammatory bowel disease (116)
Inflation Reduction Act (8)
Influenza (21)
Intellectual property (68)
Interviews (21)
IPO (8411)
IRA (14)
Job creations (1616)
Job search strategy (159)
Kidney cancer (8)
Labor market (5)
Layoffs (226)
Leadership (4)
Legal (1552)
Liver cancer (36)
Lung cancer (225)
Lymphoma (113)
Machine learning (3)
Management (9)
Manufacturing (190)
MASH (57)
Medical device (3963)
Medtech (3965)
Mergers & acquisitions (7861)
Metabolic disorders (437)
Multiple sclerosis (56)
NASH (17)
Neurodegenerative disease (71)
Neuropsychiatric disorders (26)
Neuroscience (1294)
NextGen: Class of 2025 (2450)
Non-profit (1058)
Northern California (1818)
Now hiring (21)
Obesity (221)
Opinion (110)
Ovarian cancer (66)
Pain (46)
Pancreatic cancer (56)
Parkinson's disease (125)
Partnered (8)
Patents (134)
Patient recruitment (83)
Peanut (35)
People (29376)
Pharmaceutical (49)
Pharmacy benefit managers (5)
Phase I (15204)
Phase II (19721)
Phase III (12460)
Pipeline (916)
Policy (54)
Postmarket research (893)
Preclinical (6271)
Press Release (36)
Prostate cancer (68)
Psychedelics (35)
Radiopharmaceuticals (222)
Rare diseases (307)
Real estate (3170)
Recruiting (16)
Regulatory (9561)
Reports (19)
Research institute (1020)
Resumes & cover letters (24)
Rett syndrome (4)
RNA editing (5)
RSV (18)
Schizophrenia (61)
Series A (105)
Series B (71)
Service/supplier (1)
Sickle cell disease (40)
Southern California (1600)
Special edition (11)
Spinal muscular atrophy (118)
Sponsored (15)
Startups (2137)
State (1)
Stomach cancer (5)
Supply chain (30)
Tariffs (18)
The Weekly (42)
United States (14504)
Vaccines (254)
Venture capitalists (32)
Weight loss (133)
Women's health (16)
Worklife (2)
Date
Today (97)
Last 7 days (561)
Last 30 days (1673)
Last 365 days (21469)
2025 (6940)
2024 (22581)
2023 (24688)
2022 (31084)
2021 (32253)
2020 (26971)
2019 (19347)
2018 (14110)
2017 (15598)
2016 (13356)
2015 (16156)
2014 (11644)
2013 (8429)
2012 (8699)
2011 (8850)
2010 (8441)
Location
Africa (184)
Alabama (44)
Alaska (3)
Arizona (65)
Arkansas (7)
Asia (19642)
Australia (3306)
California (4147)
Canada (1232)
China (387)
Colorado (171)
Connecticut (161)
Delaware (104)
Europe (42082)
Florida (509)
Georgia (124)
Idaho (23)
Illinois (283)
India (14)
Indiana (131)
Iowa (4)
Japan (85)
Kansas (64)
Kentucky (9)
Louisiana (7)
Maine (42)
Maryland (528)
Massachusetts (3238)
Michigan (98)
Minnesota (171)
Mississippi (2)
Missouri (32)
Montana (15)
Nebraska (6)
Nevada (27)
New Hampshire (38)
New Jersey (1044)
New Mexico (17)
New York (1141)
North Carolina (610)
North Dakota (5)
Northern California (1818)
Ohio (120)
Oklahoma (11)
Oregon (24)
Pennsylvania (806)
Puerto Rico (7)
Rhode Island (20)
South America (306)
South Carolina (8)
South Dakota (1)
Southern California (1600)
Tennessee (52)
Texas (497)
Utah (66)
Virginia (84)
Washington D.C. (31)
Washington State (371)
West Virginia (2)
Wisconsin (19)
306,214 Results for "expansion therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
RION names Biopharma Veteran Suneet Varma as Senior Advisor to Spearhead Expansion into Regenerative Therapeutics
May 1, 2025
·
2 min read
FDA
J&J Wins Crohn’s Expansion for Tremfya as Stelara Biosimilars Enter US Market
The label expansion could help J&J establish Tremfya as a successor to Stelara, which is now facing a growing biosimilar challenge.
March 21, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Eterna Therapeutics Announces Expansion of Scientific Advisory Board
January 28, 2025
·
4 min read
Approvals
AstraZeneca, Daiichi Sankyo Continue ADC Rally With Enhertu Expansion
Enhertu’s label expansion comes on the heels of the FDA’s approval of the partners’ Datroway for a related type of breast cancer.
January 28, 2025
·
2 min read
·
Tristan Manalac
Cancer
BeiGene Gets Yet Another Label Expansion for PD-1 Drug Tevimbra
The approval for the first-line treatment of esophageal squamous cell carcinoma comes shortly after a label expansion for the drug in gastric and gastroesophageal cancers as BeiGene also pushes forward a pipeline of novel cancer therapies.
March 4, 2025
·
2 min read
·
Dan Samorodnitsky
Press Releases
NorthSea Therapeutics Announces Expansion of Leadership Team with Key Industry Veteran Hires
February 20, 2025
·
5 min read
Immunology and inflammation
Lilly’s I&I Push Gains Momentum With Omvoh Expansion
Omvoh’s label expansion is important progress for Eli Lilly as it works to diversify its portfolio beyond obesity, according to analysts from BMO Capital Markets.
January 16, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Montara Therapeutics Closes $20M Oversubscribed Seed Expansion, Appoints Troy Wilson as Chairman of the Board
March 14, 2025
·
4 min read
BioMidwest
DiaMedica Therapeutics Announces Expansion of DM199 (Rinvecalinase Alfa) Program Into Preeclampsia
DiaMedica Therapeutics Announces Expansion of DM199 (Rinvecalinase Alfa) Program Into Preeclampsia.
June 26, 2024
·
13 min read
Genetown
Inhibikase Therapeutics Announces Expansion to its Therapeutic Pipeline and Updates its Research and Development Programs
Inhibikase Therapeutics, Inc. today announced expansion of its therapeutic pipeline and multiple updates to its Research and Development programs.
June 5, 2024
·
6 min read
1 of 30,622
Next
